Medical reprocessing market sees renewed growth as healthcare providers face pressures to manage costs and increase sustainability.
The global medical sterilization, repair, and refurbishment industry is expected to reach roughly $13 billion by 2017.1
Since early 2014, the medical reprocessing index has seen renewed growth and has performed above the S&P 500.
Revenue multiples in the public markets are currently tracking at a median of 2.2x, while EBITDA multiples have a median of 8.4x. Since 2013, these have seen moderated growth rates of 10% and 14%, respectively. In 2013, revenue multiples increased from 1.6x in 2012 to reach a five-year high of 2.0x, while EBIDTA multiples have remained largely flat compared to 2012.